Author of the publication

P3.18.34 TACTI-004, a Phase 3 Trial of Eftilagimod Alfa Plus Pembrolizumab (P) + Chemotherapy (C) vs Placebo + P + C in 1St Line NSCLC

, , , , , , , , , , and . Journal of Thoracic Oncology, 20 (10, Supplement 1): S559-- (2025)Abstract | First Published on 23 October 2025.
DOI: https://doi.org/10.1016/j.jtho.2025.09.1049

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Voon, P.J
add a person with the name Voon, P.J
 

Other publications of authors with the same name

P3.18.34 TACTI-004, a Phase 3 Trial of Eftilagimod Alfa Plus Pembrolizumab (P) + Chemotherapy (C) vs Placebo + P + C in 1St Line NSCLC, , , , , , , , , and 1 other author(s). Journal of Thoracic Oncology, 20 (10, Supplement 1): S559-- (2025)Abstract | First Published on 23 October 2025.